Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MoonLake Immunotherapeutics | Chief Executive Officer, Director | Class A ordinary shares, par value $0.0001 per share | 2.98M | $167M | $55.89 | Feb 29, 2024 | Direct |
MoonLake Immunotherapeutics | Chief Executive Officer, Director | Class C ordinary shares, par value $0.0001 per share | 217K | Oct 1, 2023 | Direct | ||
MoonLake Immunotherapeutics | Chief Executive Officer, Director | Common shares, par value CHF 0.10 per share, of MoonLake AG | 5.84K | Oct 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MLTX | MoonLake Immunotherapeutics | Feb 27, 2024 | 3 | -$6.8M | 4 | Feb 29, 2024 | Chief Executive Officer, Director |
MLTX | MoonLake Immunotherapeutics | Feb 21, 2024 | 1 | -$62.2K | 4 | Feb 23, 2024 | Chief Executive Officer, Director |
MLTX | MoonLake Immunotherapeutics | Feb 15, 2024 | 3 | -$3.56M | 4 | Feb 20, 2024 | Chief Executive Officer, Director |
MLTX | MoonLake Immunotherapeutics | Oct 1, 2023 | 6 | $0 | 4 | Oct 3, 2023 | Chief Executive Officer, Director |
MLTX | MoonLake Immunotherapeutics | Apr 5, 2022 | 0 | $0 | 3 | Apr 15, 2022 | Chief Executive Officer, Director |